B1 oligomerization regulates PML nuclear body biogenesis and leukemogenesis.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
22 08 2019
Historique:
received: 11 12 2018
accepted: 02 08 2019
entrez: 24 8 2019
pubmed: 24 8 2019
medline: 1 1 2020
Statut: epublish

Résumé

ProMyelocyticLeukemia (PML) protein can polymerize into a mega-Dalton nuclear assembly of 0.1-2 μm in diameter. The mechanism of PML nuclear body biogenesis remains elusive. Here, PML

Identifiants

pubmed: 31439836
doi: 10.1038/s41467-019-11746-0
pii: 10.1038/s41467-019-11746-0
pmc: PMC6706441
doi:

Substances chimiques

Oncogene Proteins, Fusion 0
Promyelocytic Leukemia Protein 0
RARA protein, human 0
Retinoic Acid Receptor alpha 0
PML protein, human 143220-95-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3789

Références

Cell. 2002 Jan 25;108(2):165-70
pubmed: 11832207
Cell. 2006 Jun 16;125(6):1137-49
pubmed: 16777603
Cancer Cell. 2006 Apr;9(4):249-60
pubmed: 16616331
Nat Cell Biol. 2000 Oct;2(10):730-6
pubmed: 11025664
Acta Crystallogr D Biol Crystallogr. 2001 Jan;57(Pt 1):122-33
pubmed: 11134934
Cancer Discov. 2013 Jun;3(6):636-47
pubmed: 23558953
J Cell Sci. 1999 Feb;112 ( Pt 3):381-93
pubmed: 9885291
Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1601-6
pubmed: 8643677
Elife. 2016 Jun 02;5:
pubmed: 27253059
J Appl Crystallogr. 2012 Mar 15;45(Pt 2):342-350
pubmed: 25484842
Cancer Cell. 2006 Feb;9(2):95-108
pubmed: 16473277
Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
pubmed: 15299374
Cell Biosci. 2015 Nov 04;5:60
pubmed: 26539288
Structure. 2017 Jun 6;25(6):867-877.e3
pubmed: 28528776
Oncogene. 2011 Apr 14;30(15):1822-30
pubmed: 21217775
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15103-8
pubmed: 10611345
Oncogene. 2001 Oct 29;20(49):7250-6
pubmed: 11704853
Blood. 2004 May 15;103(10):3876-82
pubmed: 14751928
Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3978-83
pubmed: 9108090
Proc Natl Acad Sci U S A. 1999 May 25;96(11):6318-23
pubmed: 10339585
Cancer Cell. 2003 Aug;4(2):99-110
pubmed: 12957285
Biophys J. 2002 Feb;82(2):1096-111
pubmed: 11806949
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8878-83
pubmed: 8799121
Cancer Cell. 2010 Feb 17;17(2):186-97
pubmed: 20159610
Cancer Cell. 2005 Feb;7(2):143-53
pubmed: 15710327
Nat Rev Mol Cell Biol. 2007 Dec;8(12):1006-16
pubmed: 17928811
EMBO J. 1995 Dec 1;14(23):5947-56
pubmed: 8846787
Biochemistry. 2008 Oct 7;47(40):10722-30
pubmed: 18795805
Cell. 2006 Jul 28;126(2):269-83
pubmed: 16873060
Oncogene. 2002 Mar 7;21(11):1633-40
pubmed: 11896594
Mol Pharmacol. 2007 Oct;72(4):993-1002
pubmed: 17609419
EMBO J. 1998 Jan 2;17(1):61-70
pubmed: 9427741
Leukemia. 2011 May;25(5):814-20
pubmed: 21331069
J Cell Sci. 2008 Aug 15;121(Pt 16):2731-43
pubmed: 18664490
Biochemistry. 2008 Feb 26;47(8):2450-7
pubmed: 18220417
J Cell Biol. 2014 Mar 17;204(6):931-45
pubmed: 24637324
Nat Commun. 2018 Mar 29;9(1):1277
pubmed: 29599493
Exp Cell Res. 1992 Oct;202(2):211-23
pubmed: 1397076
Nature. 2006 Aug 17;442(7104):779-85
pubmed: 16915281
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Oncogene. 2001 Oct 29;20(49):7223-33
pubmed: 11704850
Nature. 1998 Feb 19;391(6669):815-8
pubmed: 9486655
Nature. 2000 Jul 13;406(6792):207-10
pubmed: 10910364
Bull Assoc Fr Etud Cancer. 1960 Oct-Dec;47:570-84
pubmed: 13776183
Cell Cycle. 2016 Dec;15(23):3210-3219
pubmed: 27754743
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
J Biomol NMR. 2014 Dec;60(4):275-81
pubmed: 25355412
Blood. 1995 Aug 1;86(3):862-7
pubmed: 7620182
J Struct Biol. 2016 Sep;195(3):282-285
pubmed: 27402535
Blood. 2000 May 1;95(9):2748-52
pubmed: 10779416
Cancer Cell. 2007 Jul;12(1):36-51
pubmed: 17613435
Mol Cell. 2006 Nov 3;24(3):331-9
pubmed: 17081985
J Biol Chem. 2013 Sep 27;288(39):27836-48
pubmed: 23940047
Cancer Cell. 2017 May 8;31(5):697-710.e7
pubmed: 28486108
J Cell Sci. 1997 Sep;110 ( Pt 18):2197-205
pubmed: 9378769
Nat Rev Cancer. 2011 Oct 07;11(11):792-804
pubmed: 21979307
Oncogene. 1989 Oct;4(10):1175-83
pubmed: 2571965
Science. 1995 Mar 10;267(5203):1498-502
pubmed: 7878469
Cancer Cell. 2005 Jan;7(1):87-99
pubmed: 15652752
Nat Struct Biol. 1999 May;6(5):458-63
pubmed: 10331874
Blood. 2004 Aug 15;104(4):919-22
pubmed: 15130940

Auteurs

Yuwen Li (Y)

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.

Xiaodan Ma (X)

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.

Zhiming Chen (Z)

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.

Haiyan Wu (H)

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.

Pengran Wang (P)

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.

Wenyu Wu (W)

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.

Nuo Cheng (N)

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.

Longhui Zeng (L)

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.

Hao Zhang (H)

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.

Xun Cai (X)

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.

Sai-Juan Chen (SJ)

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.

Zhu Chen (Z)

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.

Guoyu Meng (G)

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China. guoyumeng@shsmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH